Atherogenic indices in clinical practice and biomedical research: A short review


  • Hussein A. Abid Medical Laboratory Technology Department, Technical Institute of Baquba, Middle Technical University, Baqubah 32001, Iraq
  • Zainab S. Abid Health Directorate of Diyala, Ministry of Health, Baqubah 32001, Iraq
  • Shireen A. Abid Department of Chemistry, Faculty of Science, University of Diyala, Baqubah 32001, Iraq



atherogenic index of plasma, atherogenic coefficient, coronary artery disease, dyslipidemia, lipid ratios


Cardiovascular diseases (CVD) represent a major cause of mortality and morbidity worldwide. To date, many physicians still requesting traditional lipid profile tests (TG, TC, HDL-C, and LDL-C) to confirm the clinical diagnosis related to CVD. However, using these tests may be inadequate for the prediction of CVD risk, especially in intermediate risk. For better clinical practice, laboratory diagnostic alternatives should constantly be evaluated and developed by physicians and laboratory scientists. In this review, we sought to focus on the benefits of lipid ratios (CRI-, CRI-II, AIP, AC, and CHOLindex) in supporting clinical diagnosis and how they can be calculated. To attain this aim, a literature search in reputed databases (PubMed and Scopus) was performed and peer-reviewed research articles were included to conduct this review. Short theoretical and practical notes about each index were accordingly included along with calculation formulas. Thus, the current article can assist new researchers and young physicians to review what supports their knowledge in managing early CVDs.    


Metrics Loading ...


Download data is not yet available.


Altan Onat et al. ““Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular events”. J Clin Lipidol 4(2) (2010), pp. 89–98. DOI: 10.1016/j.jacl.2010.02.005.

Apiradee Sriwijitkamol and Tamon Sangsawang. “Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital”. Vasc Health Risk Manag 563 (2015), pp. 563–563. DOI: 10.2147/vhrm.s92461.

Attila Brehm et al. “Relationship between serum lipoprotein ratios and insulin resistance in obesity”. Clin Chem 50(12) (2004), pp. 2316–2322. DOI: 10.1373/clinchem.2004.037556.

C I Okafor. “The metabolic syndrome in Africa: Current trends”. Indian J Endocrinol Metab 16(1) (2012), pp. 56–66. DOI: 10.4103/2230-8210.91191.

Charles Amir German and Michael David Shapiro. “Assessing atherosclerotic cardiovascular disease risk with advanced lipid testing: State of the science”. Eur Cardiol 15 (2020). DOI: 10.15420/ecr.2019.18.

Deepu Nair et al. “Association of total cholesterol/ high-density lipoprotein cholesterol ratio with proximal coronary atherosclerosis detected by multislice computed tomography”. Prev Cardiol 12(1) (2009), pp. 19–26. DOI: 10.1111/j.1751-7141.2008.00011.x.

Duygu Tecer et al. “Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?” Adv Rheumatol 59(1) (2019). DOI: 10.1186/s42358-019-0096-2.

Enrique Gómez-Álvarez et al. “The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico”. Int J Cardiol Heart Vasc 29 (2020). DOI: 10.1016/j.ijcha.2020.100545.

F H Rached, M J Chapman, and A Kontush. “An overview of the new frontiers in the treatment of atherogenic dyslipidemias”. Clin Pharmacol Ther 96(1) (2014), pp. 57–63. DOI: 10.1038/clpt.2014.85.

G Igharo. “Lipid profile and atherogenic indices in Nigerians occupationally exposed to e-waste: A cardiovascular risk assessment study”. Maedica 15(2) (2020), pp. 196–205. DOI: 10.26574/maedica.2020.15.2.196.

Gaojun Cai et al. “The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population”. Medicine 96(37) (2017), e8058–e8058. DOI: 10.1097/md.0000000000008058.

Gökhan Çakırca and Muhammet Murat Çelik. “Lipid profile and atherogenic indices and their association with platelet indices in familial Mediterranean fever”. Turk Kardiyol Dern Ars 46 (2018), pp. 184–190. DOI: 10.5543/tkda.2018.93762.

H. Robert Superko and Spencer King. “Lipid management to reduce cardiovascular risk: A new strategy is required”. Circulation 117(4) (2008), pp. 560–568. DOI: 10.1161/circulationaha.106.667428.

Ivona Markeli´c et al. “Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease”. Nutr Metab Cardiovasc Dis 31(1) (2021), pp. 153–161. DOI: 10.1016/j.numecd.2020.07.039.

J Perk et al. “European guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re”. Eur Heart J 33(13) (2012), pp. 1635–1701. DOI: 10.1093/eurheartj/ehs092.

Jorge Sapunar et al. “High prevalence of dyslipidemia and high atherogenic index of plasma in children and adolescents”. Rev Med Chil 146(10) (2018), pp. 1112–1122. DOI: 10.4067/S0034-98872018001001112.

Juan C. Fernández-Macías et al. “Atherogenic Index of Plasma: Novel predictive biomarker for cardiovascular illnesses”. Arch Med Res 50(5) (2019), pp. 285–294. DOI: 10.1016/j.arcmed.2019.08.009.

K Bora et al. “Association of the apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from assam, Northeast India”. Balk J Med Genet 20(1) (2017), pp. 59–70. DOI: 10.1515/bjmg-2017-0002.

K.Sarat Chandra et al. “Consensus statement on management of dyslipidemia in Indian subjects”. Indian Heart J 66(Supplement 3) (2014), pp. 1–51. DOI: 10.1016/j.ihj.2014.12.001.

Kemal Ertas and Cemal Nas. “Relationship between atherogenic indices and acquired premature ejaculation”. Andrologia 53(2) (2021). DOI: 10.1111/and.13906.

Luzhao Wang et al. “Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score”. Angiology 72(2) (2021), pp. 181–186. DOI: 10.1177/0003319720949804.

M Aguirre. “Triglycerides/High density lipoprotein cholesterol ratio as a cardiometabolic risk marker in children and adolescents from Mérida city, Venezuela”. Endocrinol Diabetes Nutr (Engl Ed) 65(2) (2018), pp. 74–83. DOI: 10.1016/j.endinu.2017.10.010.

M H Criqui and B A Golomb. “Epidemiologic aspects of lipid abnormalities”. Am J Med 105(1A) (1998), pp. 48–57. DOI: 10.1016/s0002-9343(98)00212-5.

Maria G. Frontini et al. “Utility of non–high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (the Bogalusa heart study)”. Am J Cardiol 100(1) (2007), pp. 64–68. DOI: 10.1016/j.amjcard.2007.01.071.

Mehmet Gokhan Culha et al. “The correlation between atherogenic indexes and erectile dysfunction”. Aging Male 23(5) (2020), pp. 1232–1236. DOI: 10.1080/13685538.2020.1749996.

MichaelAdeyemi Olamoyegun, Rotimi Oluyombo, and StephenOlabode Asaolu. “Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria”. Ann Afr Med 15(4) (2016), pp. 194–194. DOI: 10.4103/1596-3519.194280.

Milada Dobiášová et al. “Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography”. J Lipid Res 52(3) (2011), pp. 566–571. DOI: 10.1194/jlr.p011668.

Nalan Hakime Nogay. “Assessment of the correlation between the atherogenic index of plasma and cardiometabolic risk factors in children and adolescents: might it be superior to the TG/HDL-C ratio?” J Pediatr Endocrinol Metab 30(9) (2017), pp. 947–955. DOI: 10.1515/jpem-2016-0479.

Onur Akpinar et al. “A new index (CHOLINDEX) in detecting coronary artery disease risk”. Anatol J Cardiol 13(4) (2013), pp. 315–319. DOI: 10.5152/akd.2013.098.

P Greenland, S C Smith, and S M Grundy. “Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests”. Circulation 104(15) (2001), pp. 1863–1870. DOI: 10.1161/hc4201.097189.

R E Ulusoy. “LDL cholesterol measurement in terms of CHOLINDEX”. Anatol J Cardiol 13(6) (2013), p. 612. DOI: 10.5152/akd.2013.208.

R H Nelson. “Hyperlipidemia as a risk factor for cardiovascular disease”. Prim Care 40(1) (2013), pp. 195–211. DOI: 10.1016/j.pop.2012.11.003.

S O V Nunes. “Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder”. J Affect Disord 172 (2015), pp. 55–62. DOI: 10.1016/j.jad.2014.09.038.

S. Bhardwaj et al. “Atherogenic index of plasma, Castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk”. Int J Pharm Biol Sci 3(3) (2013), pp. 359–364.

Salazar MR et al. “Use of the triglyceride/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity”. J Investig Med 65(2) (2017), pp. 323–327. DOI: 10.1136/jim-2016-000248.

Steve Raoul Noumegni et al. “Atherogenic index of plasma and 10-year risk of cardiovascular disease in adult Africans living with HIV infection: A cross-sectional study from Yaoundé, Cameroon”. JRSM Cardiovasc Dis 6 (2017), pp. 1–7. DOI: 10.1177/2048004017740478.

Sudip Datta Banik, Elda Pacheco-Pantoja, Roberto Lugo, et al. “Evaluation of anthropometric indices and lipid parameters to predict metabolic syndrome among adults in Mexico”. Diabetes Metab Syndr Obes 14 (2021), pp. 691–701.

T R H Nielsen. “Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents”. BMC Pediatr 17 (2017), p. 116. DOI: 10.1186/s12887-017-0868-y.

T T Koca et al. “The clinical importance of the plasma atherogenic index, other lipid indexes, and urinary sodium and potassium excretion in patients with stroke”. Eurasian J Med 51(2) (2019), pp. 172–176. DOI: 10.5152/eurasianjmed.2019.18350.

W P Castelli, R D Abbott, and P M McNamara. “Summary estimates of cholesterol used to predict coronary heart disease.” Circulation 67(4) (1983), pp. 730–734. DOI: 10.1161/01.cir.67.4.730. URL:

Yadon Arad et al. “Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events”. J Am Coll Cardiol 46(1) (2005), pp. 158–165. DOI: 10.1016/j.jacc.2005.02.088.

Zuhal Çalı¸skan. “Lipid profile atherogenic indices and their relation of epicardial fat thickness and carotid intima media thickness in Celiac disease”. North Clin Istanb 6 (2019), pp. 242–247. DOI: 10.14744/nci.2019.54936.



How to Cite

Atherogenic indices in clinical practice and biomedical research: A short review. (2021). Baghdad Journal of Biochemistry and Applied Biological Sciences, 2(02), 60-70.